Form 4 for INCY Incyte
Accepted 2023-07-18 00:00:00 ET · period of report 2023-07-14 · accession 0001209191-23-042547 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-18 | 2023-07-14 | INCY | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +43.2K | 434.9K | +11% | $0 |
| D | 2023-07-18 | 2023-07-14 | INCY | Hoppenot Herve | COB, CEO, Dir, Pres | A - Grant | $0.00 | +90.6K | 90.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-14 | A | A | 43,184 | $0.00 | 434,856 | D | — | — | (F1) Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Herve Hoppenot's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. (F2) Including the July 14, 2023 RSU Grant, this includes an aggregate of 133,685 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-07-14 | A | A | 90,563 | $0.00 | 90,563 | D | $61.76 · — to 2033-07-13 | 90,563 Common Stock | (F3) The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |